+44 (0) 2036426654 [email protected]

Clinical Trial Services, UK | PHARMExcel - PHARMExcel is a full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery.
Skip to content
  • About
    • People
    • Quality
    • Testimonials
    • Careers
  • Therapeutic Areas
  • Sectors
    • NHS/University Trials
    • Biotech Solutions
    • ATMP Studies
    • Medical Device CRO Services
    • Rare Disease
  • Services
  • Insights
    • News & Studies
    • Blogs
    • Case Studies
    • Events & Awards
    • Published Research
  • Contact

Home » News and Events » News & Studies » PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters

PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters

Posted on 10th May 2022

Share this page
This entry was posted in News & Studies
Clinical Trial Services, UK | PHARMExcel - PHARMExcel is a full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery.

CRO Solutions

  • Home
  • Therapeutic Areas
  • Services
  • Request an RFP
  • Client Feedback

Company

  • About
  • People
  • Quality Policy
  • ESG (Including EDI)
  • Anti Sexual Harassment Statement
  • Careers
  • Fundraising

+44 (0) 2036426654
[email protected]

HQ:

Albany Chambers, 26 Bridge Road East, Welwyn Garden City, Herts, AL7 1HL, UK

Resources

  • News
  • Blogs
  • Glossary
  • Case Study
  • Events & Awards
  • Our Published Research
Investors in People Gold Award logo
SEHTA award logo
  • Privacy Policy

  •  | 

  • Cookie Policy

  •  | 

  • Site map

  •  | 

© Copyright 2026 PHARMExcel | Website by Union 10 Design